XML 36 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Dec. 08, 2021
Nov. 23, 2021
Aug. 22, 2021
Dec. 07, 2020
Oct. 28, 2020
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2021
Realized through sale of shares           $ 100,000    
Weighted average grant date fair value           $ 5.65    
Fair value of stock option           $ 28,000    
Proceeds from issuance of common stock             $ 13,559,500  
Consulting Agreements [Member]                
Total expense inclued prepaid expenses           234,000   $ 364,000
Total expense           $ 218,000 $ 249,000  
Non-Qualified Stock Option Plans [Member]                
Grant performance-based stock options           250,000    
Common stock price           $ 10.48    
Stock options vest           100.00%    
Series W Warrants [Member]                
Warrants exercised         688,930      
Common stock price per share         $ 16.75      
Consultants [Member]                
Expiration date           November 17, 2022    
Options issued           5,000    
Consultants One [Member]                
Options issued           15,000    
Non-Qualified Stock Option shares vest           15,000    
Restricted Stock [Member] | Consultants [Member]                
Weighted average grant date fair value           $ 9.93 $ 12.45  
Common stock issued for service, shares           18,020 15,044  
December 2020 [Member]                
Common stock shares           1,000,000    
Offering price           $ 14.65    
Proceeds from issuance of common stock           $ 13,600,000    
Series X [Member]                
Incremental cost           $ 85,000    
Expiration date description       the expiration date of the Series X warrants was extended six months from January 13, 2021 to July 13, 2021        
Expiration date           7/13/2022    
Series Y [Member]                
Incremental cost           $ 41,000    
Expiration date           8/15/2022    
Series NN [Member]                
Warrants exercised           4,500    
Proceeds from warrants exercised           $ 11,340    
Exercise price of warrants exercised           $ 2.52    
Expiration date           7/24/2022    
Series TT [Member]                
Warrants exercised           10,000    
Proceeds from warrants exercised           $ 22,400    
Exercise price of warrants exercised           $ 2.24    
Expiration date           2/5/2023    
Series CC [Member]                
Proceeds from warrants exercised           $ 76,000 $ 25,000  
Exercise price per share $ 5.00         $ 5.00 $ 5.00  
Warrants expired during period 640         15,205 5,000  
Series Z [Member]                
Warrants exercised   184,800            
Common stock price per share   $ 13.75            
Series BB [Member]                
Warrants expired during period     16,000          
Common stock price per share     $ 13.75          
Series N Warrants [Member]                
Incremental cost           $ 1,000    
Expiration date description       the expiration date of the Series N warrants was extended six months from February 18, 2021 to August 18, 2021        
Series UU warrants [Member]                
Incremental cost           $ 192    
Expiration date description       the expiration date of Series UU warrants was extended six months from December 31, 2020 to June 30, 2021